The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker
NCT01071525
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hypercholesterolemia
Interventions
DRUG:
Niacin\Laropiprant
Sponsor
Rambam Health Care Campus